In addition, both studies targeting glioblastoma epitopes showed that mutant peptide epitopes favored expansion of cytotoxic CD4+ T-cells (115) and even if peptides were used to target CD8+ T-cells, peptide antigen-specific CD4+ T-cell expansion was observed in both studies (88). The gene discussed is CD4; the disease is glioblastoma.